Wilmington, Delaware, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Global Sexually Transmitted Diseases Testing Market size is valued at US$ 8.5 billion in 2023 and is predicted to rise at a substantial CAGR of 7.6% during the forecast period of 2023 and 2030 according to RationalStat analysis.
Market Definition, Market Scope, and Report Overview
The process of identifying the presence of sexually transmitted infections (STIs) or diseases in people who are sexually active or at risk of developing the infection is referred to as sexually transmitted diseases (STD) testing. STD testing is necessary to detect conditions early, start treatment promptly, and stop the disease from spreading to new sexual partners.
If left untreated, many STDs can result in serious health issues such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, chronic discomfort, and a higher chance of developing particular cancers. The likelihood of these consequences is decreased by early detection and treatment made possible by STD testing.
- According to a deep-dive market assessment by RationalStat, the sexually transmitted diseases testing market has been analyzed on the basis of market segments, including product, location of testing, application, end user, and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the sexually transmitted diseases testing market covers market sizes based on market value (US$/EUR Million) and volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the sexually transmitted diseases testing market. It also includes the industry's current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-sexually-transmitted-diseases-testing-market/#tab-ux_global_tab
Global Sexually Transmitted Diseases Testing Market: Segmental and Market Share Analysis
- Based on the Location of testing, the laboratory testing segment is expected to account for majority of the market share as most of the cases of diagnostic testing are carried out in labs.
Report Synopsis
| Report Metrics | Details |
| Base Year | 2023 |
| Forecast Period | 2023-2030 |
| Base Year Market Size | US$ 8.5 billion |
| Market Size Forecast | US$ 14.2 billion |
| Growth Rate | 7.6% |
| Dominant Segment | Laboratory Testing Segment |
| Leading Region | North America |
| Key Market Drivers |
|
| Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-sexually-transmitted-diseases-testing-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Some of the prominent players adopt various strategies to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, and partnerships and collaborations are some of the strategies followed by industry players, some of the key developments in the sexually transmitted diseases testing market include,
- In February 2023, Hoffman-La Roche Ltd. entered into a Public-Private Partnership (PPP) named Lab Networks for Health with the U.S. CDC to improve HIV and TB detection, prevention, and treatment in countries in Africa, Eastern Europe, Central Asia, Latin America, and the Caribbean countries that have been affected the most by HIV and tuberculosis (TB) epidemics.
- In August 2022, Thermo Fisher Scientific Inc. launched Applied Biosystems HIV-1 Genotyping Kit that detects drug resistant strains of HIV-1.
Some of the prominent players and suppliers operating and contributing significantly to the sexually transmitted diseases testing market growth include Hoffmann-La Roche Ltd, Abbott, BD, Hologic Inc., Thermo Fisher Scientific Inc., bioMerieux Inc, Danaher Corporation, Bio-Rad Laboratories, Inc., and DiaSorin S.p.A, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-sexually-transmitted-diseases-testing-market/#tab-ux_global_tab
RationalStat has segmented the sexually transmitted diseases testing market based on product, location of testing, application, end user, and region
- Global Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Product
- Instruments
- Reagents & Kits
- Global Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Location of Testing
- Laboratory Testing
- Point-of-Care
- Global Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Application
- Chlamydia
- Syphilis
- Genital Herpes
- Gonorrhea
- Human Immunodeficiency Virus
- Human Papillomavirus
- Others
- Global Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by End User
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Global Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Region
- North America Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- US
- Canada
- Latin America Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Sexually Transmitted Diseases Testing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
For more information about this report- https://store.rationalstat.com/store/global-sexually-transmitted-diseases-testing-market/
Key Questions Answered in the Sexually Transmitted Diseases Testing Report:
- What will be the market value of the sexually transmitted diseases testing market by 2030?
- What is the market size of the sexually transmitted diseases testing market?
- What are the market drivers of the sexually transmitted diseases testing market?
- What are the key trends in the sexually transmitted diseases testing market?
- Which is the leading region in the sexually transmitted diseases testing market?
- What are the major companies operating in the sexually transmitted diseases testing market?
- What are the market shares by key segments in the sexually transmitted diseases testing market?
Running a Year End Discount of 20%- https://store.rationalstat.com/store/global-sexually-transmitted-diseases-testing-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global Metastatic Colorectal Cancer Therapeutics Market- Global metastatic colorectal cancer therapeutics market is anticipated to attain a value of US$ 7.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
- Global Dermatology Lasers Market- Global Dermatology Lasers Market is expected to grow at a CAGR of 7.3% over the forecast period of 2022-2028
- Global Pharmaceutical Contract Manufacturing Market- Global pharmaceutical contract manufacturing market is anticipated to grow at a CAGR of 7.9%
- Global Biologics Contract Manufacturing Market- Global biologics contract manufacturing market is anticipated to grow at a CAGR of 9.5%
- Global Benign Prostatic Hyperpl Medication - Global Benign Prostatic Hyperpl Medication Market is expected to grow at a CAGR of 5.0% over the forecast period of 2022-2028.
- Global Red Light Therapy Device Market-Global Red Light Therapy Device Market is expected to grow at a significant CAGR of 4.2% over the forecast period of 2022-2028.
- US Pharmacy Market- US pharmacy market is anticipated to attain a value of US$ 706 million by 2030, growing at a compound annual growth rate (CAGR) of 3.9% during the forecast period.
- Global Retinoblastoma Treatment Market- global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
- Global Pet Relaxants Market- Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
- Global Metastatic Colorectal Cancer Therapeutics Market- Global metastatic colorectal cancer therapeutics market is anticipated to attain a value of US$ 7.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
- Global Retinoblastoma Treatment Market- global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
- Global Pet Relaxants Market- Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoints to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data - Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest
